Skip to main content
OpenTrials
Completed

NCT Number: NCT06197737

Specific Modified Exercise Program for Patients Having Chronic Asthma

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Abasyn University

Islamabad, Federal Capital, 46000, Pakistan

About this study

Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients having chronic asthma
  • Age between 15-25 years.
  • Participants having no dyspnea at rest .
  • Participants scoring 13 or less on borg scale
  • Exclusion Criteria
  • History of co-morbidities.
  • History of recent fractures.
  • Participants scoring greater than 13 on BORG scale

Exclusion criteria

  • Exercise induced asthma (evaluated through BRUCE protocol).
  • Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
  • Patients score falling 15 or more on Borg scale.

Treatment and study plan

Moderate Intensity Interval Training

Other

Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.

Sprint Interval Training

Other

sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

pharmacological treatment

Other

They will be on pharmacological treatment as prescribed by their pulmonologist.

Primary outcomes

  1. Assessment of change in the Inspiratory Capacity

    Time frame: Baseline, 8th week and then 16th week

    It will measured using an incentive spirometer

  2. Assessment of change in the Pulmonary Function

    Time frame: Baseline, 8th week and then 16th week

    Electronic spirometer will be used to measure all the parameters of pulmonary function.

  3. Assessment of change in the Oxygen saturation

    Time frame: Baseline, 8th week and then 16th week

    Measured using pulse oximeter before, during and after the intervention.

  4. Assessment of change in the Rate of perceived exertion / dyspnea

    Time frame: Baseline, 8th week and then 16th week

    measured through borg scale during the assigned intervention

  5. Assessment of change in the cardiovascular endurance

    Time frame: Baseline, 8th week and then 16th week

    PACER test for cardiovascular endurance test

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects of Moderate Intensity Interval Training and Sprint Interval Training on Patients Having Chronic Asthma.

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 9, 2024
Registry last updated
May 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.